Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Medicis acquires Graceway Pharmaceuticals' assets for US$455 million

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Medicis Pharmaceuticals

Medicis Pharmaceuticals Corporation, a leading independent specialty pharmaceutical corporation in the United States and Canada, completed its acquisition of substantially all of the U.S. and Canadian assets of Graceway Pharmaceutical, LLC for US$455 million. Graceway filed for Chapter 11 bankruptcy protection on September 29, 2011, and Medicis was the successful bidder in the bankruptcy auction approved by both the U.S. and Canadian bankruptcy courts. Medicis was assisted on the Canadian legal aspects of the transaction by a team that included Timothy Squire (regulatory), Scott Conover (corporate, mergers & acquisitions), Aubrey Kauffman and Stuart Brotman (insolvency/restructuring), Richard Cheung (regulatory), Ian Campbell (labour), Paul Casuccio (tax), Kevin Holbeche (IP), Paul King (real estate), Ronald Nobrega (tax) and Juho Song (corporate).

Team

    Subscribe

    Receive email updates from our team

    Subscribe